Literature DB >> 22340933

Elevated uric acid increases the risk for acute kidney injury.

Vijay Lapsia1, Richard J Johnson, Bhagwan Dass, Michiko Shimada, Ganesh Kambhampati, Noel I Ejaz, Amir A Arif, A Ahsan Ejaz.   

Abstract

BACKGROUND: Uric acid has been proposed to play a role in acute kidney injury. We therefore investigated the potential influence of preoperative serum uric acid (SUA) on acute kidney injury in patients undergoing cardiovascular (CV) surgery. The primary aims were to investigate the incidence of acute kidney injury, peak serum creatinine (SCr) concentrations, hospital length of stay, and days on mechanical ventilation.
METHODS: Retrospective study included patients who underwent CV surgery and had preoperative SUA available. Acute kidney injury was defined as an absolute increase in SCr ≥0.3 mg/dL from baseline within 48 hours after surgery. Univariate and multivariate logistic regression analysis was performed to determine the odds ratio for acute kidney injury.
RESULTS: There were 190 patients included for analysis. SUA were divided into deciles. The incidences of acute kidney injury were higher with higher deciles of SUA. When the incidences of acute kidney injury were plotted against all available values of SUA at increments of 0.5 mg/dL, a J-shaped curve emerged demonstrating higher incidences of acute kidney injury associated with both hypo- and hyperuricemia. In the univariate analysis, SUA ≥5.5 mg/dL was associated with a 4-fold (odds ratio [OR] 4.4; 95% confidence interval [CI], 2.4-8.2), SUA ≥6 mg/dL with a 6-fold (OR 5.9; 95% CI, 3.2-11.3), SUA ≥6.5 mg/dL with an 8-fold (OR 7.9; 95% CI, 3.9-15.8), and SUA ≥7 mg/dL with a 40-fold (OR 39.1; 95% CI, 11.6-131.8) increased risk for acute kidney injury. In the multivariate analysis, SUA ≥7 mg/dL also was associated with a 35-fold (OR 35.4; 95% CI, 9.7-128.7) increased risk for acute kidney injury. The 48-hour postoperative and hospital-stay mean peak SCr levels also were higher in the SUA ≥5.5 mg/dL group compared with the SUA <5 mg/dL group. SUA ≥7 mg/dL was associated with increased length of hospital stay (SUA <7 mg/dL, 18.5 ± 1.8 days vs SUA ≥7 mg/dL, 32.0 ± 6.8 days, P = 0.058) and a longer duration of mechanical ventilation support (SUA <7 mg/dL, 2.4 ± 0.4 days vs SUA ≥7 mg/dL, 20.4 ± 4.5 days, P = 0.001).
CONCLUSION: Preoperative SUA was associated with increased incidence and risk for acute kidney injury, higher postoperative SCr values, and longer hospital length of stay and duration of mechanical ventilation support in patients undergoing cardiac surgery. A J-shaped relationship appears to exist between SUA and acute kidney injury. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22340933     DOI: 10.1016/j.amjmed.2011.06.021

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  36 in total

1.  Effect of uric acid lowering therapy on the prevention of acute kidney injury in cardiovascular surgery.

Authors:  A Ahsan Ejaz; Bhagwan Dass; Vijaykumar Lingegowda; Michiko Shimada; Thomas M Beaver; Noel I Ejaz; Amer S Abouhamze; Richard J Johnson
Journal:  Int Urol Nephrol       Date:  2012-05-31       Impact factor: 2.370

2.  Is uric acid an underdiagnosed mediator of adverse outcome in metabolically healthy overweight/obese individuals?

Authors:  Mehdi A Fini; Richard M Wright; Kurt R Stenmark; Stephen R Daniels; Richard J Johnson
Journal:  Am J Med       Date:  2014-06       Impact factor: 4.965

3.  Serum Uric Acid Levels and Renal Impairment among ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Intervention.

Authors:  Yacov Shacham; Amir Gal-Oz; Nir Flint; Gad Keren; Yaron Arbel
Journal:  Cardiorenal Med       Date:  2016-02-25       Impact factor: 2.041

Review 4.  Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation.

Authors:  Richard J Johnson; George L Bakris; Claudio Borghi; Michel B Chonchol; David Feldman; Miguel A Lanaspa; Tony R Merriman; Orson W Moe; David B Mount; Laura Gabriella Sanchez Lozada; Eli Stahl; Daniel E Weiner; Glenn M Chertow
Journal:  Am J Kidney Dis       Date:  2018-02-27       Impact factor: 8.860

Review 5.  Acute kidney injury among ST elevation myocardial infarction patients treated by primary percutaneous coronary intervention: a multifactorial entity.

Authors:  Yacov Shacham; Arie Steinvil; Yaron Arbel
Journal:  J Nephrol       Date:  2016-02-10       Impact factor: 3.902

6.  Plasma Urate and Risk of a Hospital Stay with AKI: The Atherosclerosis Risk in Communities Study.

Authors:  Keiko I Greenberg; Mara A McAdams-DeMarco; Anna Köttgen; Lawrence J Appel; Josef Coresh; Morgan E Grams
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-25       Impact factor: 8.237

7.  Serum uric acid level as a risk factor for acute kidney injury in hospitalized patients: a retrospective database analysis using the integrated medical information system at Kochi Medical School hospital.

Authors:  Kazunori Otomo; Taro Horino; Takeo Miki; Hiromi Kataoka; Yutaka Hatakeyama; Tatsuki Matsumoto; Kazu Hamada-Ode; Yoshiko Shimamura; Koji Ogata; Kosuke Inoue; Yoshinori Taniguchi; Yoshio Terada; Yoshiyasu Okuhara
Journal:  Clin Exp Nephrol       Date:  2015-09-11       Impact factor: 2.801

8.  Hyperuricemia is associated with a lower glomerular filtration rate in pediatric sickle cell disease patients.

Authors:  Cristin D W Kaspar; Isidora Beach; Jennifer Newlin; India Sisler; Daniel Feig; Wally Smith
Journal:  Pediatr Nephrol       Date:  2020-01-20       Impact factor: 3.714

Review 9.  Comorbidities in patients with crystal diseases and hyperuricemia.

Authors:  Sebastian E Sattui; Jasvinder A Singh; Angelo L Gaffo
Journal:  Rheum Dis Clin North Am       Date:  2014-02-19       Impact factor: 2.670

Review 10.  Hyperuricemia in Kidney Disease: A Major Risk Factor for Cardiovascular Events, Vascular Calcification, and Renal Damage.

Authors:  Abutaleb Ahsan Ejaz; Takahiko Nakagawa; Mehmet Kanbay; Masanari Kuwabara; Ada Kumar; Fernando E Garcia Arroyo; Carlos Roncal-Jimenez; Fumihiko Sasai; Duk-Hee Kang; Thomas Jensen; Ana Andres Hernando; Bernardo Rodriguez-Iturbe; Gabriela Garcia; Dean R Tolan; Laura G Sanchez-Lozada; Miguel A Lanaspa; Richard J Johnson
Journal:  Semin Nephrol       Date:  2020-11       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.